Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models - Archive ouverte HAL Access content directly
Journal Articles Statistics in Medicine Year : 2012

Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models

(1) , (1, 2) , (1)
1
2

Abstract

Bioequivalence or interaction trials are commonly studied in crossover design and can be analysed by nonlinear mixed effects models as an alternative to noncompartmental approach. We propose an extension of the population Fisher information matrix in nonlinear mixed effects models to design crossover pharmacokinetic trials, using a linearisation of the model around the random effect expectation, including within-subject variability and discrete covariates fixed or changing between periods. We use the expected standard errors of treatment effect to compute the power for the Wald test of comparison or equivalence and the number of subjects needed for a given power. We perform various simulations mimicking crossover two-period trials to show the relevance of these developments. We then apply these developments to design a crossover pharmacokinetic study of amoxicillin in piglets and implement them in the new version 3.2 of the r function PFIM.
Fichier principal
Vignette du fichier
Manuscript1HAL.pdf (266.66 Ko) Télécharger le fichier
Vignette du fichier
SupplementaryMaterial1HAL.pdf (18.19 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Format : Other

Dates and versions

inserm-00629594 , version 1 (06-10-2011)

Identifiers

Cite

Thu Thuy Nguyen, Caroline Bazzoli, France Mentré. Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models. Statistics in Medicine, 2012, 31 (11-12), pp.1043-1058. ⟨10.1002/sim.4390⟩. ⟨inserm-00629594⟩
346 View
832 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More